Comorbid substance use disorders in schizophrenia: A latent class approach

被引:22
|
作者
Kerner, Befit [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Schizophrenia; Substance use disorders; Family history of psychosis; Dependence; Disease course; Major depressive disorder; AGE-OF-ONSET; CANNABIS USE DISORDERS; ALCOHOL-USE DISORDERS; FAMILY-HISTORY; GENETIC LIABILITY; DUAL DIAGNOSIS; RISK-FACTORS; GENOME-WIDE; DRUG-ABUSE; FOLLOW-UP;
D O I
10.1016/j.psychres.2014.12.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Schizophrenia is a complex psychiatric disorder with a characteristic disease course and heterogeneous etiology. While substance use disorders and a family history of psychosis have individually been identified as risk factors for schizophrenia, it is less well understood if and how these factors are related. To address this deficiency, we examined the relationship between substance use disorders and family history of psychosis in a sample of 1219 unrelated patients with schizophrenia. The lifetime rate of substance use disorders in this sample was 50%, and 30% had a family history of psychosis. Latent class mixture modeling identified three distinct patient subgroups: (1) individuals with low probability of substance use disorders; (2) patients with drug and alcohol abuse, but no symptoms of dependence; and (3) patients with substance dependence. Substance use was related to being male, to a more severe disease course, and more acute symptoms at assessment, but not to an earlier age of onset of schizophrenia or a specific pattern of positive and negative symptoms. Furthermore, substance use in schizophrenia was not related to a family history of psychosis. The results suggest that substance use in schizophrenia is an independent risk factor for disease severity and onset. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 50 条
  • [1] Treating comorbid substance use disorders in schizophrenia
    Lubman, Dan I.
    King, Joel A.
    Castle, David J.
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2010, 22 (02) : 191 - 201
  • [2] Morbidity and mortality in schizophrenia with comorbid substance use disorders
    Lahteenvuo, Markku
    Batalla, Albert
    Luykx, Jurjen J.
    Mittendorfer-Rutz, Ellenor
    Tanskanen, Antti
    Tiihonen, Jari
    Taipale, Heidi
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 42 - 49
  • [3] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [4] Treatment for Outpatients with Comorbid Schizophrenia and Substance Use Disorders: A Review
    De Witte, Nele A. J.
    Crunelle, Cleo L.
    Sabbe, Bernard
    Moggi, Franz
    Dom, Geert
    [J]. EUROPEAN ADDICTION RESEARCH, 2014, 20 (03) : 105 - 114
  • [5] Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
    Lahteenvuo, M.
    Batalla, A.
    Luykx, J.
    Mittendorfer-Rutz, E.
    Tanskanen, A.
    Tiihonen, J.
    Taipale, H.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S237 - S238
  • [6] Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
    Prat, Gemma
    Marquez-Arrico, Julia E.
    Rio-Martinez, Laura
    Navarro, Jose Francisco
    Adan, Ana
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110
  • [7] Comorbid substance use and age at onset of schizophrenia
    Barnes, TRE
    Mutsatsa, SH
    Hutton, SB
    Watt, HC
    Joyce, EM
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 237 - 242
  • [8] Treatment of Schizophrenia and Comorbid Substance Use Disorder
    Green, Alan, I
    Salomon, Melinda S.
    Brenner, Mark J.
    Rawlins, Kimberly
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 129 - 139
  • [9] Suicide in personality disorders with substance use disorders comorbid
    Martinez Riera, R.
    Mateu Codina, G. -A.
    Diaz Digon, L.
    Castillo Buenaventura, C.
    Roig Llesuy, J.
    Vallecillo Sanchez, G.
    Morro Fernandez, L.
    Torrens Melich, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 73 - 73
  • [10] SUBSTANCE USE AND COMORBID PSYCHOPATHOLOGY CHARACTERISTICS IN YOUNG TREATMENT-SEEKING SUBSTANCE USERS: A LATENT CLASS ANALYSIS
    Mefodeva, Valeriya
    Chan, Gary C. K.
    Carlyle, Molly
    Hides, Leanne
    [J]. DRUG AND ALCOHOL REVIEW, 2021, 40 : S106 - S107